Cost-Effectiveness of Hypothetical New Cancer Drugs in Patients with Advanced Small-Cell Lung Cancer: Results of a Markov Chain Model

BACKGROUND: In the last decade, a number of new treatment modalities have been developed for patients with small cell lung cancer (SCLC). The clinical effects are encouraging, but little is known about the costs and cost-effectiveness of new drugs. METHODS: A Markov chain model has been developed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Uyl-de Groot, Carin A, McDonnell, Joseph, ten Velde, Guul, Radice, David, Groen, Harry J M
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2006
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936268/
https://www.ncbi.nlm.nih.gov/pubmed/18360607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936268/
https://www.ncbi.nlm.nih.gov/pubmed/18360607

Ejemplares similares